1. Home
  2. MDXG vs INVA Comparison

MDXG vs INVA Comparison

Compare MDXG & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • INVA
  • Stock Information
  • Founded
  • MDXG 2006
  • INVA 1996
  • Country
  • MDXG United States
  • INVA United States
  • Employees
  • MDXG N/A
  • INVA N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • INVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDXG Health Care
  • INVA Health Care
  • Exchange
  • MDXG Nasdaq
  • INVA Nasdaq
  • Market Cap
  • MDXG 1.0B
  • INVA N/A
  • IPO Year
  • MDXG N/A
  • INVA 2004
  • Fundamental
  • Price
  • MDXG $7.25
  • INVA $18.61
  • Analyst Decision
  • MDXG Strong Buy
  • INVA Buy
  • Analyst Count
  • MDXG 3
  • INVA 1
  • Target Price
  • MDXG $12.00
  • INVA $55.00
  • AVG Volume (30 Days)
  • MDXG 815.1K
  • INVA 661.3K
  • Earning Date
  • MDXG 04-30-2025
  • INVA 05-07-2025
  • Dividend Yield
  • MDXG N/A
  • INVA N/A
  • EPS Growth
  • MDXG N/A
  • INVA N/A
  • EPS
  • MDXG 0.27
  • INVA N/A
  • Revenue
  • MDXG $352,375,000.00
  • INVA $369,844,000.00
  • Revenue This Year
  • MDXG $9.23
  • INVA $0.08
  • Revenue Next Year
  • MDXG $11.49
  • INVA $10.19
  • P/E Ratio
  • MDXG $26.71
  • INVA N/A
  • Revenue Growth
  • MDXG 5.34
  • INVA 18.70
  • 52 Week Low
  • MDXG $5.47
  • INVA $14.90
  • 52 Week High
  • MDXG $10.14
  • INVA $21.28
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 54.99
  • INVA 60.02
  • Support Level
  • MDXG $6.53
  • INVA $18.05
  • Resistance Level
  • MDXG $7.52
  • INVA $18.90
  • Average True Range (ATR)
  • MDXG 0.34
  • INVA 0.31
  • MACD
  • MDXG 0.11
  • INVA -0.01
  • Stochastic Oscillator
  • MDXG 81.63
  • INVA 67.42

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: